US Stock MarketDetailed Quotes

ACET Adicet Bio

Watchlist
  • 0.830
  • -0.020-2.33%
Close Mar 28 16:00 ET
  • 0.828
  • -0.002-0.26%
Post 20:01 ET
68.65MMarket Cap-0.62P/E (TTM)

Adicet Bio Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
-3.74%127.62M
-2.61%30.74M
1.08%33.15M
-5.85%32.85M
-7.36%30.87M
35.92%132.58M
0.00%31.57M
42.70%32.8M
53.65%34.89M
64.28%33.32M
Selling and administrative expenses
6.63%28.29M
9.74%7.47M
4.03%6.9M
6.43%6.95M
6.21%6.97M
0.91%26.53M
3.92%6.81M
3.40%6.63M
-0.02%6.53M
-3.46%6.57M
-General and administrative expense
6.63%28.29M
9.74%7.47M
4.03%6.9M
6.43%6.95M
6.21%6.97M
0.91%26.53M
3.92%6.81M
3.40%6.63M
-0.02%6.53M
-3.46%6.57M
Research and development costs
-6.34%99.32M
-6.00%23.27M
0.33%26.25M
-8.68%25.9M
-10.69%23.9M
48.84%106.04M
-1.02%24.76M
57.92%26.17M
75.31%28.36M
98.44%26.76M
Operating profit
3.74%-127.62M
2.61%-30.74M
-1.08%-33.15M
5.85%-32.85M
7.36%-30.87M
-82.73%-132.58M
-0.00%-31.57M
-42.70%-32.8M
-53.65%-34.89M
-808.07%-33.32M
Net non-operating interest income expense
7.61%10.71M
-5.14%2.07M
8.34%2.73M
14.86%3M
10.16%2.92M
170.46%9.95M
1.16%2.18M
108.87%2.52M
750.49%2.61M
18,807.14%2.65M
Non-operating interest income
7.38%10.71M
-5.10%2.07M
8.33%2.73M
14.68%3M
9.45%2.92M
165.37%9.98M
-0.05%2.18M
105.88%2.52M
704.62%2.62M
8,231.25%2.67M
Non-operating interest expense
-84.00%4K
--1K
0.00%1K
--0
-89.47%2K
-68.75%25K
--0
-94.44%1K
-77.78%4K
5.56%19K
Other net income (expense)
98.92%-217K
50.50%-50K
99.72%-54K
58.87%-51K
70.39%-61K
-2,080.09%-20.04M
78.19%-101K
-8,934.10%-19.6M
10.14%-124K
-101.96%-206K
Special income (charges)
--0
--0
--0
----
----
---19.46M
--0
---19.46M
----
----
-Less:Impairment of capital assets
--0
--0
--0
----
----
--19.46M
--0
--19.46M
----
----
Other non- operating income (expenses)
62.13%-217K
50.50%-50K
61.97%-54K
58.87%-51K
70.39%-61K
37.65%-573K
78.19%-101K
34.56%-142K
10.14%-124K
-101.96%-206K
Income before tax
17.90%-117.12M
2.58%-28.73M
38.90%-30.48M
7.72%-29.9M
9.28%-28.02M
-104.41%-142.66M
1.29%-29.49M
-126.79%-49.89M
-43.77%-32.4M
-768.71%-30.88M
Income tax
0
0
0
0
0
0
0
0
0
0
Net income
17.90%-117.12M
2.58%-28.73M
38.90%-30.48M
7.72%-29.9M
9.28%-28.02M
-104.41%-142.66M
1.29%-29.49M
-126.79%-49.89M
-43.77%-32.4M
-768.71%-30.88M
Net income continuous Operations
17.90%-117.12M
2.58%-28.73M
38.90%-30.48M
7.72%-29.9M
9.28%-28.02M
-104.41%-142.66M
1.29%-29.49M
-126.79%-49.89M
-43.77%-32.4M
-768.71%-30.88M
Minority interest income
Net income attributable to the parent company
17.90%-117.12M
2.58%-28.73M
38.90%-30.48M
7.72%-29.9M
9.28%-28.02M
-104.41%-142.66M
1.29%-29.49M
-126.79%-49.89M
-43.77%-32.4M
-768.71%-30.88M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
17.90%-117.12M
2.58%-28.73M
38.90%-30.48M
7.72%-29.9M
9.28%-28.02M
-104.41%-142.66M
1.29%-29.49M
-126.79%-49.89M
-43.77%-32.4M
-768.71%-30.88M
Basic earnings per share
59.82%-1.33
52.94%-0.32
70.69%-0.34
56.00%-0.33
51.39%-0.35
-94.71%-3.31
5.56%-0.68
-118.87%-1.16
-33.93%-0.75
-700.00%-0.72
Diluted earnings per share
59.82%-1.33
52.94%-0.32
70.69%-0.34
56.00%-0.33
51.39%-0.35
-94.71%-3.31
5.56%-0.68
-118.87%-1.16
-33.93%-0.75
-820.00%-0.72
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense -3.74%127.62M-2.61%30.74M1.08%33.15M-5.85%32.85M-7.36%30.87M35.92%132.58M0.00%31.57M42.70%32.8M53.65%34.89M64.28%33.32M
Selling and administrative expenses 6.63%28.29M9.74%7.47M4.03%6.9M6.43%6.95M6.21%6.97M0.91%26.53M3.92%6.81M3.40%6.63M-0.02%6.53M-3.46%6.57M
-General and administrative expense 6.63%28.29M9.74%7.47M4.03%6.9M6.43%6.95M6.21%6.97M0.91%26.53M3.92%6.81M3.40%6.63M-0.02%6.53M-3.46%6.57M
Research and development costs -6.34%99.32M-6.00%23.27M0.33%26.25M-8.68%25.9M-10.69%23.9M48.84%106.04M-1.02%24.76M57.92%26.17M75.31%28.36M98.44%26.76M
Operating profit 3.74%-127.62M2.61%-30.74M-1.08%-33.15M5.85%-32.85M7.36%-30.87M-82.73%-132.58M-0.00%-31.57M-42.70%-32.8M-53.65%-34.89M-808.07%-33.32M
Net non-operating interest income expense 7.61%10.71M-5.14%2.07M8.34%2.73M14.86%3M10.16%2.92M170.46%9.95M1.16%2.18M108.87%2.52M750.49%2.61M18,807.14%2.65M
Non-operating interest income 7.38%10.71M-5.10%2.07M8.33%2.73M14.68%3M9.45%2.92M165.37%9.98M-0.05%2.18M105.88%2.52M704.62%2.62M8,231.25%2.67M
Non-operating interest expense -84.00%4K--1K0.00%1K--0-89.47%2K-68.75%25K--0-94.44%1K-77.78%4K5.56%19K
Other net income (expense) 98.92%-217K50.50%-50K99.72%-54K58.87%-51K70.39%-61K-2,080.09%-20.04M78.19%-101K-8,934.10%-19.6M10.14%-124K-101.96%-206K
Special income (charges) --0--0--0-----------19.46M--0---19.46M--------
-Less:Impairment of capital assets --0--0--0----------19.46M--0--19.46M--------
Other non- operating income (expenses) 62.13%-217K50.50%-50K61.97%-54K58.87%-51K70.39%-61K37.65%-573K78.19%-101K34.56%-142K10.14%-124K-101.96%-206K
Income before tax 17.90%-117.12M2.58%-28.73M38.90%-30.48M7.72%-29.9M9.28%-28.02M-104.41%-142.66M1.29%-29.49M-126.79%-49.89M-43.77%-32.4M-768.71%-30.88M
Income tax 0000000000
Net income 17.90%-117.12M2.58%-28.73M38.90%-30.48M7.72%-29.9M9.28%-28.02M-104.41%-142.66M1.29%-29.49M-126.79%-49.89M-43.77%-32.4M-768.71%-30.88M
Net income continuous Operations 17.90%-117.12M2.58%-28.73M38.90%-30.48M7.72%-29.9M9.28%-28.02M-104.41%-142.66M1.29%-29.49M-126.79%-49.89M-43.77%-32.4M-768.71%-30.88M
Minority interest income
Net income attributable to the parent company 17.90%-117.12M2.58%-28.73M38.90%-30.48M7.72%-29.9M9.28%-28.02M-104.41%-142.66M1.29%-29.49M-126.79%-49.89M-43.77%-32.4M-768.71%-30.88M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 17.90%-117.12M2.58%-28.73M38.90%-30.48M7.72%-29.9M9.28%-28.02M-104.41%-142.66M1.29%-29.49M-126.79%-49.89M-43.77%-32.4M-768.71%-30.88M
Basic earnings per share 59.82%-1.3352.94%-0.3270.69%-0.3456.00%-0.3351.39%-0.35-94.71%-3.315.56%-0.68-118.87%-1.16-33.93%-0.75-700.00%-0.72
Diluted earnings per share 59.82%-1.3352.94%-0.3270.69%-0.3456.00%-0.3351.39%-0.35-94.71%-3.315.56%-0.68-118.87%-1.16-33.93%-0.75-820.00%-0.72
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------
Market Insights
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.